DSpace

King Saud University Repository >
King Saud University >
COLLEGES >
Health Colleges >
College of Pharmacy >
College of Pharmacy >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/2280

Title: Safety and mechanism of action of orlistat (tetrahydrolipstatin) as the first local antiobesity drug
Authors: Al-Suwailem, K.
Al-Tamimi, A.S.
Al-Omar, M.A.
Al-Suhibani, M.S.
Keywords: Orlistat
Sibutramine
Obesity
Overweight
Antiobesity drug
Issue Date: 2006
Publisher: INSInet Publication
Citation: Journal of Applied Sciences Research: 2(4); 205-208
Abstract: The benefits of orlistat, a new anti-obesity drug, have been assessed in this mini-review. The mechanism of action,as well as the clinical privilege of this peripheral acting drug on central acting drugs such as sibutramine,was discussed. Mono-and combined therapies for controlling the obesity are reported in short and long-term therapy. Data were collected using MEDLINE search drug (June 1998-February 2005) using the terms: orlistat, sibutramine, obesity, overweight and antiobesity drug. Relevant references cited in the bibliography of related article also included were as possible. The search was not limitedby language, gender or age, however only human sample has been consider. The aim of this review article is to assess the therapeutic efficacy of orlistat in glance.
URI: http://www.insinet.net/jasr/2006/205-208.pdf
http://hdl.handle.net/123456789/2280
ISSN: 1816-157X
Appears in Collections:College of Pharmacy

Files in This Item:

File Description SizeFormat
Safety and mechanism of action of orlistat (tetrahydrolipstatin) as the first local antiobesity drug.pdf39.19 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard - Feedback